Authors of HHS report criticize recent STAT op-ed on gender-affirming care for minors for using “scare tactics.” ...
Hims & Hers will stop selling what it claims to be a cheaper, compounded version of Novo Nordisk's obesity pill on its telehealth platform.
FDA will take “decisive steps” to thwart companies from mass marketing unapproved, compounded versions of GLP-1 drugs ...
Opinion
As a scientist and NFL widow, I am furious about a recent NFL Players Association-funded CTE study
As a scientist, I am disgusted. As an NFL widow who witnessed unimaginable suffering, I am furious,” writes Eleanor M. Perfetto.
WASHINGTON — President Trump said his administration’s new TrumpRx website will offer the cheapest prices in the world for 43 ...
In a small trial, Roivant's immune drug significantly outperformed placebo in clearing lesions caused by a rare skin disease.
Doctors are not a flock of free-range chickens wandering about offices and hospitals and making up best practices, one ...
China criticized the United States for withdrawing from the WHO, saying countries should not place domestic politics ahead of ...
In Denmark, pediatrician Michael Thwing once saw nearly 20 infants admitted simultaneously with rotavirus. His experience in ...
Four drug companies — Agomab Therapeutics, Eikon Therapeutics, Spyglass Pharma, and Veradermics — went public this week, ...
The Trump administration is moving forward with a personnel rule that critics say will subject a broader swath of the federal workforce to political pressure ...
ARPA-H, the “moonshot” biomedical agency established under the Biden administration, laid off staff last week, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results